The Feasibility of taVNS on Pregnancy Outcomes of Infertility Patients Undergoing IVF
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Infertility Assisted Reproductive Technology
In brief
To assess the feasibility of taVNS on pregnancy outcomes of infertility subjects undergoing IVF, the primary aim of this trial will focus on encompassing recruitment, compliance, and preliminary engagement outcomes. The exploratory aim is to carry out clinical research, which entails evaluating the preliminary effects of the intervention in order to ascertain its potential benefits. The main question it aims to answer is: Does the taVNS is feasible and tolerated in the context of IVF? What medical problems do participants have when using the taVNS device? Researchers will compare the taVNS to the sham transcutaneous auricular vagus nerve stimulation (a look-alike device that produces a sub-threshold therapeutic stimulus and functions as a sham stimulus) and blank control to see if the taVNS device works to enhance outcomes of IVF. Participants will: Use the device a total of 1.5 hours daily, with the sessions divided into three parts, each lasting 30 minutes. At least one of these periods occur within 2 hours before bedtime. Visit the clinic according to the scheduled treatment time points of IVF. Keep a diary of their adverse events and the number of times they use the device.
Key facts
- Study ID
- NCT06742788
- Run by
- Xijing Hospital
- People needed
- 90
- Starts
- 2025-03-04
- Expected to finish
- 2027-12-30
- Last updated by the study team
- 2026-08-06
Who can join
Age: 20 and older, up to 40. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects aged 20 to 40 years, diagnosed with infertility, and preparing to undergo IVF treatment;
- Female subjects with anti-Müllerian hormone (AMH) > 1.2 ng/mL;
- Scoring at mild-to-moderate levels of impairment on anxiety, and depression scales;
- Both the subject and their family sign the informed consent form.
You may not qualify if…
- The subject had been treated with taVNS in the past;
- Subjects preparing to undergo frozen embryo transfer;
- Subjects with a history of mental disorder or who score at a severe level of impairment on anxiety and depression scales;
- Taking sedatives, anxiety, depression, or psychiatric medications;
- Comorbidities including arrhythmia, hypertension, diabetes, chronic heart and kidney diseases;
- Ineligibility for enrollment assessed by a gynecologist or neurologist;
- Metallic implants or devices contraindicating taVNS.
Where it is running
- Xijing Hospital — Xi'an, Shaanxi, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.